RATIONALE: Surfactant protein A (SP-A) is a collectin family member that has multiple immunomodulatory roles in lung host defense. SP-A levels are altered in the bronchoalveolar lavage (BAL) fluid and serum of patients with acute lung injury and acute respiratory distress syndrome, suggesting the importance of SP-A in the pathogenesis of acute lung injury. OBJECTIVES: Investigate the role of SP-A in the murine model of noninfectious lung injury induced by bleomycin treatment. METHODS: Wild-type (WT) or SP-A deficient (SP-A(-/-)) mice were challenged with bleomycin, and various indices of lung injury were analyzed. MEASUREMENTS AND MAIN RESULTS: On challenge with bleomycin, SP-A(-/-) mice had a decreased survival rate as compared with WT mice. SP-A(-/-) mice had a higher degree of neutrophil-dominant cell recruitment and the expression of the inflammatory cytokines in BAL fluid than did WT mice. In addition, SP-A(-/-) mice had increased lung edema as assessed by the increased levels of intravenously injected Evans blue dye leaking into the lungs. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling and active caspase-3 staining suggested the increased apoptosis in the lung sections from SP-A(-/-) mice challenged with bleomycin. SP-A also specifically reduced bleomycin-induced apoptosis in mouse lung epithelial 12 cells in vitro. Moreover, intratracheal administration of exogenous SP-A rescued the phenotype of SP-A(-/-) mice in vivo. CONCLUSIONS: These data suggest that SP-A plays important roles in modulating inflammation, apoptosis, and epithelial integrity in the lung in response to acute noninfectious challenges.
RATIONALE: Surfactant protein A (SP-A) is a collectin family member that has multiple immunomodulatory roles in lung host defense. SP-A levels are altered in the bronchoalveolar lavage (BAL) fluid and serum of patients with acute lung injury and acute respiratory distress syndrome, suggesting the importance of SP-A in the pathogenesis of acute lung injury. OBJECTIVES: Investigate the role of SP-A in the murine model of noninfectious lung injury induced by bleomycin treatment. METHODS: Wild-type (WT) or SP-A deficient (SP-A(-/-)) mice were challenged with bleomycin, and various indices of lung injury were analyzed. MEASUREMENTS AND MAIN RESULTS: On challenge with bleomycin, SP-A(-/-) mice had a decreased survival rate as compared with WT mice. SP-A(-/-) mice had a higher degree of neutrophil-dominant cell recruitment and the expression of the inflammatory cytokines in BAL fluid than did WT mice. In addition, SP-A(-/-) mice had increased lung edema as assessed by the increased levels of intravenously injected Evans blue dye leaking into the lungs. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling and active caspase-3 staining suggested the increased apoptosis in the lung sections from SP-A(-/-) mice challenged with bleomycin. SP-A also specifically reduced bleomycin-induced apoptosis in mouse lung epithelial 12 cells in vitro. Moreover, intratracheal administration of exogenous SP-A rescued the phenotype of SP-A(-/-) mice in vivo. CONCLUSIONS: These data suggest that SP-A plays important roles in modulating inflammation, apoptosis, and epithelial integrity in the lung in response to acute noninfectious challenges.
Authors: P Borron; J C McIntosh; T R Korfhagen; J A Whitsett; J Taylor; J R Wright Journal: Am J Physiol Lung Cell Mol Physiol Date: 2000-04 Impact factor: 5.464
Authors: K E Greene; J R Wright; K P Steinberg; J T Ruzinski; E Caldwell; W B Wong; W Hull; J A Whitsett; T Akino; Y Kuroki; H Nagae; L D Hudson; T R Martin Journal: Am J Respir Crit Care Med Date: 1999-12 Impact factor: 21.405
Authors: Jeffrey W Card; James W Voltz; Michelle A Carey; J Alyce Bradbury; Laura M Degraff; Fred B Lih; James C Bonner; Daniel L Morgan; Gordon P Flake; Darryl C Zeldin Journal: Am J Respir Cell Mol Biol Date: 2007-05-11 Impact factor: 6.914
Authors: Friedemann J H Taut; Gerd Rippin; Peter Schenk; George Findlay; Wilhelm Wurst; Dietrich Häfner; James F Lewis; Werner Seeger; Andreas Günther; Roger G Spragg Journal: Chest Date: 2008-08-08 Impact factor: 9.410
Authors: Lisa N Henning; Abul K Azad; Kishore V L Parsa; Joy E Crowther; Susheela Tridandapani; Larry S Schlesinger Journal: J Immunol Date: 2008-06-15 Impact factor: 5.422
Authors: Andreas Schwingshackl; Benjamin Lopez; Bin Teng; Charlean Luellen; Florian Lesage; John Belperio; Riccardo Olcese; Christopher M Waters Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-08-24 Impact factor: 5.464
Authors: Alane Blythe C Dy; Muhammad Z Arif; Kenneth J Addison; Loretta G Que; Scott Boitano; Monica Kraft; Julie G Ledford Journal: J Immunol Date: 2019-07-26 Impact factor: 5.422
Authors: Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam Journal: Am J Respir Cell Mol Biol Date: 2013-08 Impact factor: 6.914